ATE252094T1 - Imidazol derivate mit proteinkinase, insbesondere egf-r tyrosinkinase, inhibierender wirkung - Google Patents

Imidazol derivate mit proteinkinase, insbesondere egf-r tyrosinkinase, inhibierender wirkung

Info

Publication number
ATE252094T1
ATE252094T1 AT95941646T AT95941646T ATE252094T1 AT E252094 T1 ATE252094 T1 AT E252094T1 AT 95941646 T AT95941646 T AT 95941646T AT 95941646 T AT95941646 T AT 95941646T AT E252094 T1 ATE252094 T1 AT E252094T1
Authority
AT
Austria
Prior art keywords
inhibiting effect
imidazole derivatives
kinase
protein kinase
tyrosine kinase
Prior art date
Application number
AT95941646T
Other languages
English (en)
Inventor
Charles Stanford Harmon
Markus Kamber
Anna Krasso
Wolfang Pirson
Pierre-Charles Wyss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE252094T1 publication Critical patent/ATE252094T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
AT95941646T 1994-12-13 1995-12-01 Imidazol derivate mit proteinkinase, insbesondere egf-r tyrosinkinase, inhibierender wirkung ATE252094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH376894 1994-12-13
PCT/EP1995/004741 WO1996018626A1 (en) 1994-12-13 1995-12-01 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase

Publications (1)

Publication Number Publication Date
ATE252094T1 true ATE252094T1 (de) 2003-11-15

Family

ID=4263074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941646T ATE252094T1 (de) 1994-12-13 1995-12-01 Imidazol derivate mit proteinkinase, insbesondere egf-r tyrosinkinase, inhibierender wirkung

Country Status (16)

Country Link
US (1) US5959113A (de)
EP (1) EP0797575B1 (de)
JP (1) JPH10510281A (de)
CN (1) CN1145623C (de)
AR (1) AR003406A1 (de)
AT (1) ATE252094T1 (de)
AU (1) AU4301096A (de)
BR (1) BR9509998A (de)
CA (1) CA2207404C (de)
DE (1) DE69531956T2 (de)
DK (1) DK0797575T3 (de)
ES (1) ES2208698T3 (de)
FI (1) FI972492L (de)
PT (1) PT797575E (de)
TR (1) TR199501561A2 (de)
WO (1) WO1996018626A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083949A (en) * 1995-10-06 2000-07-04 Merck & Co., Inc. Substituted imidazoles having anti-cancer and cytokine inhibitory activity
JP2001504490A (ja) * 1996-11-20 2001-04-03 メルク エンド カンパニー インコーポレーテッド トリアリール置換イミダゾール、そのような化合物を含む組成物及び使用方法
US5880139A (en) * 1996-11-20 1999-03-09 Merck & Co., Inc. Triaryl substituted imidazoles as glucagon antagonists
JP2000514088A (ja) * 1996-11-20 2000-10-24 メルク エンド カンパニー インコーポレーテッド グルカゴンアンタゴニストとしてのトリアリール置換イミダゾール
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
AU4506399A (en) * 1998-06-05 1999-12-30 Novartis Ag Aryl pyridinyl thiazoles
AU4395399A (en) * 1998-07-02 2000-01-24 Sankyo Company Limited Five-membered heteroaryl compounds
JP3850596B2 (ja) 1999-02-25 2006-11-29 本州化学工業株式会社 新規な部分保護トリスフェノール類とその製造方法
WO2003024447A1 (en) * 2001-09-20 2003-03-27 Smithkline Beecham Corporation Inhibitors of glycogen synthase kinase-3
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
US6790852B2 (en) * 2002-04-18 2004-09-14 Hoffmann-La Roche Inc. 2-(2,6-dichlorophenyl)-diarylimidazoles
ES2497116T3 (es) 2002-08-19 2014-09-22 Lorus Therapeutics Inc. Imidazoles 2,4,5-trisustituidos y su uso como agentes antimicrobianos
US7144889B2 (en) * 2003-10-16 2006-12-05 Hoffman-La Roche Inc. Triarylimidazoles
CN100436450C (zh) * 2003-10-16 2008-11-26 霍夫曼-拉罗奇有限公司 三芳基咪唑
US7169781B2 (en) 2003-10-17 2007-01-30 Hoffmann-La Roche Inc. Imidazole derivatives and their use as pharmaceutical agents
CA2545942C (en) 2003-11-14 2012-07-10 Lorus Therapeutics Inc. Aryl imidazoles and their use as anti-cancer agents
CN101080399B (zh) * 2005-02-18 2012-12-12 独立行政法人科学技术振兴机构 光学活性环氧化合物的制造方法以及使用该方法的错合物及其制造方法
CA2611032C (en) 2005-05-25 2012-01-17 Genesense Technologies Inc. 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
JP5283872B2 (ja) 2006-09-27 2013-09-04 シスメックス株式会社 腫瘍細胞に対する阻害剤の増殖抑制効果を評価する方法、及び腫瘍細胞の増殖を阻害する化合物をスクリーニングする方法
AU2007305423A1 (en) * 2006-09-28 2008-04-10 Follica, Inc. Methods, kits, and compositions for generating new hair follicles and growing hair
WO2014153464A2 (en) 2013-03-20 2014-09-25 Lorus Therapeutics Inc. 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
CN105764511B (zh) 2013-10-04 2019-01-11 艾普托斯生物科学公司 用于治疗癌症的组合物和方法
CN106163509B (zh) 2014-02-03 2019-05-03 夸德里加生物科学公司 作为化疗剂的β-取代的β-氨基酸及类似物
US9394236B2 (en) 2014-02-03 2016-07-19 Quadriga Biosciences, Inc. β-substituted γ-amino acids and analogs as chemotherapeutic agents
US10865384B2 (en) * 2014-02-07 2020-12-15 Agency For Science, Technology And Research 2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis
JP6615983B2 (ja) 2015-08-03 2019-12-04 クワドリガ バイオサイエンシーズ， インコーポレイテッド 化学療法剤としてのβ置換βアミノ酸および類似体ならびにそれらの使用
CN109212045A (zh) * 2017-07-04 2019-01-15 万全万特制药（厦门）有限公司 草酸艾司西酞普兰残留溶剂和杂质的分离测定方法
KR20200096914A (ko) 2017-10-30 2020-08-14 압토스 바이오사이언시스 인코포레이티드 암 치료용 아릴 이미다졸
CN114262298B (zh) * 2021-12-03 2023-09-26 郑州轻工业大学 2-溴-4-n,n-二甲氨基咪唑及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
US3940486A (en) * 1971-05-10 1976-02-24 Ciba-Geigy Corporation Imidazole derivatives in the treatment of pain
CH561718A5 (de) * 1971-05-10 1975-05-15 Ciba Geigy Ag
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
IL104369A0 (en) * 1992-01-13 1993-05-13 Smithkline Beecham Corp Novel compounds and compositions
EP0624159B1 (de) * 1992-01-13 1998-11-25 Smithkline Beecham Corporation Pyridyl-substituierte imidazole
WO1994003427A1 (en) * 1992-08-06 1994-02-17 Warner-Lambert Company 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
WO1995003297A1 (en) * 1993-07-21 1995-02-02 Smithkline Beecham Corporation Imidazoles for treating cytokine mediated disease
DK0724588T3 (da) * 1993-09-17 2000-05-15 Smithkline Beecham Corp Lægemiddelbindende protein

Also Published As

Publication number Publication date
JPH10510281A (ja) 1998-10-06
AR003406A1 (es) 1998-08-05
DK0797575T3 (da) 2004-02-16
MX9704263A (es) 1997-09-30
EP0797575B1 (de) 2003-10-15
DE69531956D1 (de) 2003-11-20
US5959113A (en) 1999-09-28
AU4301096A (en) 1996-07-03
ES2208698T3 (es) 2004-06-16
CN1145623C (zh) 2004-04-14
CA2207404C (en) 2004-06-29
DE69531956T2 (de) 2004-07-29
FI972492A7 (fi) 1997-06-12
CN1175252A (zh) 1998-03-04
FI972492A0 (fi) 1997-06-12
WO1996018626A1 (en) 1996-06-20
EP0797575A1 (de) 1997-10-01
PT797575E (pt) 2004-02-27
BR9509998A (pt) 1997-12-30
TR199501561A2 (tr) 1996-07-21
CA2207404A1 (en) 1996-06-20
FI972492L (fi) 1997-06-12

Similar Documents

Publication Publication Date Title
ATE252094T1 (de) Imidazol derivate mit proteinkinase, insbesondere egf-r tyrosinkinase, inhibierender wirkung
ATE430149T1 (de) Heterocyclen substituierte imidazopyrazine als protein- tyrosin-kinase-inhibitoren
EP1109803A4 (de) Substituierte imidazole mit cytokin-inhibierender wirkung
ATE255575T1 (de) Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren
CY2014034I1 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
NO974453L (no) Proteinkinase C-hemmere
DE69836332D1 (de) Benzyliden-1,3-dihydro-indol-2-on-derivate als inhibitoren von rezeptor tyrosine kinasesn, insbesondere von raf kinasen
EA199800633A1 (ru) Новые замещенные производные имидазола
DE69435267D1 (de) Proteinkinase C Inhibitoren
NO20014970L (no) Cyklisk protein-tyrosin-kinase-inhibitor
FI920442L (fi) Imidazol-, triatzol- och tetrazolderivat.
DE69919734D1 (de) Terminal mit biometrischer identitätsprüfung
DE69720522D1 (de) Substituierte stickstoff enthaltende heterocyclen als p38 protein kinase inhibitoren
IS2165B (is) Týrósín kínasa latar
DE69627179D1 (de) Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren
FI950859A7 (fi) Arylideeni- ja heteroarylideeni-oksindolijohdannaiset tyrosiinikinaasi-inhibiittoreina
ATE214381T1 (de) Thiazole derivate als protein kinase c inhibitoren
ATE205836T1 (de) Bicyclische 4-aralkylaminopyrimidin-derivate als tyrosinkinase-inhibitoren
ATE387448T1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
FI955661A7 (fi) Substituoidut beta-aryyli- ja beta-heteroaryyli-alfa-syanoakryyliamidi johdannaiset tyrosiinikinaasi-inhibiittoreina
DE60119963D1 (de) Imidazol derivate, ihre herstellung und ihre verwendung
DE69920028D1 (de) Neuartige imidazole mit entzündungshemmender wirkung
DE69734817D1 (de) Neuartige amp-aktivierte proteinkinase
FI971352A7 (fi) Sytoplasminen tyrosiinikinaasi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0797575

Country of ref document: EP

REN Ceased due to non-payment of the annual fee